FDA warns J&J unit over device marketing

08/24/2010 | Los Angeles Times (tiered subscription model)

The FDA issued a warning letter to DePuy Orthopaedics saying that the Johnson & Johnson unit is selling an unapproved device, the TruMatch Personalized Solution System, and marketing another device, the Corail Hip System, for off-label uses. A DePuy statement said the company is "reviewing the letter to understand the FDA's concerns and will respond to their request for information."

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA